Compare ORIC & AGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORIC | AGNT |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | 1834 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 861.3M | 815.0M |
| IPO Year | 2020 | N/A |
| Metric | ORIC | AGNT |
|---|---|---|
| Price | $12.02 | $4.20 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $19.73 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 1.2M |
| Earning Date | 05-05-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 19.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.23 | $3.85 |
| 52 Week High | $14.93 | $5.79 |
| Indicator | ORIC | AGNT |
|---|---|---|
| Relative Strength Index (RSI) | 70.89 | 46.94 |
| Support Level | $11.74 | $3.85 |
| Resistance Level | $12.58 | $4.87 |
| Average True Range (ATR) | 0.73 | 0.28 |
| MACD | 0.07 | -0.08 |
| Stochastic Oscillator | 87.22 | 36.28 |
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
AGNT Inc is a multi-model real estate platform, with brands including eXp Realty, eXp Commercial, NextHome, FrameVR.io, and SUCCESS Enterprises. The group prioritizes transparency, innovation, and long-term value for agents, franchise owners, staff, and shareholders.